How effective is Sprycel for Leukaemia?
Summary: 4 Sprycel users have rated its effectiveness for Leukaemia.
Overall ratings: 4.8/5
Long term ratings: 5.0/5
This is a review of how effective Sprycel (dasatinib) is for Leukaemia and for what kind of people. The study is created by eHealthMe and is updated continuously.
You are not alone: join a support group for people who take Sprycel for Leukaemia >>>
What is Sprycel
Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from 4,047 Sprycel users)
Leukaemia (blood or bone marrow cancer) can be treated by Gleevec. (latest reports from 3,769 Leukaemia patients)
On Mar, 26, 2015: 4 people are studied for taking Sprycel in Leukaemia
Sprycel effectiveness for Leukaemia (number of people):
|not at all||somewhat||moderate||high||very high |
Gender of people who take Sprycel for Leukaemia * :
Age of people who take Sprycel for Leukaemia * :
Who find Sprycel more effective for Leukaemia?
Gender of people who find Sprycel more effective * :
Age of people who find Sprycel more effective * :
* Approximation only. Some reports may have incomplete information.
Find out which drug is more effective in real world to treat:
What do you think? Post a comment.
Want to personalize this study to your gender and age? Start now.
Can you answer these questions (Ask a question):
More questions for: Sprycel, Leukaemia
More reviews for: Sprycel, Leukaemia
Comments from related studies:
From this study (4 weeks ago):
Right arm swelling lasting a week. No known cause.
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.